Guidance document : post-notice of compliance (NOC) changes : safety and efficacy document.: H164-271/2019E-PDF
"This guidance document applies to sponsors intending to make changes to new drugs that have received a NOC pursuant to section C.08.004 of the Food and Drug Regulations. These new drugs may include pharmaceuticals, biologics, and radiopharmaceuticals for human use and pharmaceutical and certain biotechnological products for veterinary use1, including those submissions for which a NOC has been recommended but issuance of the NOC has been placed on hold"--Introduction, page 6.
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.867837&sl=0
| Department/Agency | Canada. Health Canada, issuing body. |
|---|---|
| Title | Guidance document : post-notice of compliance (NOC) changes : safety and efficacy document. |
| Variant title | Post‐NOC changes: safety & efficacy |
| Publication type | Monograph |
| Language | [English] |
| Other language editions | [French] |
| Format | Electronic |
| Electronic document | |
| Note(s) | "Publication date: July 2019." "Date adopted: 2009/09/02; revised date: 2019/08/12; effective date: 2019/08/12." Issued also in HTML format. Issued also in French under title: Changements survenus après l’avis de conformité (AC) : document sur l’innocuité et l’efficacité. |
| Publishing information | Ottawa, ON : Health Canada = Santé Canada, 2019. ©2019 |
| Description | 1 online resource (20 pages) |
| ISBN | 9780660294506 |
| Catalogue number |
|
| Subject terms | Drugs -- Labeling -- Canada. Drug approval -- Canada. |
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.- Date modified: